Any thoughts on this company. Seemes to have good phase11 trail results in both their anti obesity drug and Irratable bowel syndrome drugs.
Much appreciated
Makes a change for a bio tech com to do well.
Thanks in advance

Let's get this in perspective - the shares have doubled in 2 weeks; nothing goes up in a continuous straight line

Did you follow the lemming?

http://www.lemminginvestor.com

I can`t find any related news about AZM in lemming web site

ckmtang:

Click on Septembers company focus. AZM is there with a whole group of other stories.

Very in good report lemming

re: "follow the lemming"

Handy to have the information all in one place, but it all appears to be c&p text from other sources.

And you can't spell Alizyme!

The spread on SETs in this company is a joke. How can they get away with this.

Well, they get away with it by not being on SETS for starters.

LOL!

LOL Sorry you are right.

Yesterday granted US patent for its anti obesity drug, valid until 2020. Hang on to your hats.

it rise a bit today morning.....

At 12.05 15 thou shares bought 3.12 ? Can some one please explain how this is possible when the shares are priced at 1.58 approx. Much appreciated.

Either a cock-up by someone who entered the order, or some poor sod fitted up like a kipper when they entered a market order: more likely the former, I suspect. I'd be surprised if that trade isn't corrected later.

AZM seemed looking good and attractive.

That rogue trade has now been deleted

Anybody into azm may also want to watch invest in Proteum science and provalis. Without going overborad these 3 stocks are way undervalued compared with US euivalents and have exponential possibilities, dyor, I hold.

It hits 3 year high, will it continue rise or shall I sell it? Or hold it?

-- ckmtang,

You really really need to read that thread referenced in post 7. It's not on MAM, but will dramatically increase your knowledge if AZM. At the end of that, you should be in a good position to decide for yourself whether or not this will continue to rise or not. In fact, just the first post, and the other thread referenced from there will give a very good grounding.

still looking good the share.